Here are relevant reports on : inflammatory-bowel-disease-treatment-market
-
Inflammatory Bowel Disease Treatment Market by Type (Crohn’s Disease, Ulcerative Colitis), Drug Class (TNF inhibitors, Corticosteroids, Aminosalicylates, JAK inhibitors, Anti-intergin, IL inhibitors, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Route of Administration (Oral, Injectable) and Region – Global Forecast to 2027
The global inflammatory bowel disease market is projected to reach USD ~32 billion by 2027 from 24 billion in 2022, at a CAGR of 5% during the forecast period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Periodontal Disease Treatment Market by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs), and Country - Forecast to 2031
The Asia Pacific peritoneal dialysis market, valued at USD 0.60 billion in 2025, stood at USD 0.64 billion in 2026 and is projected to advance at a resilient CAGR of 6.0% from 2026 to 2031, culminating in a forecasted valuation of USD 0.91 billion by the end of the period. The Asia Pacific periodontal disease treatment market is driven by the increasing prevalence of oral health disorders and the rising cases of edentulism, which are creating a growing need for effective periodontal care.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Periodontal Disease Treatment Market by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs), and Region - Global Forecast to 2030
The global periodontal disease treatment market, valued at US$2.44 billion in 2023, stood at US$2.58 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2030, culminating in a forecasted valuation of US$3.63 billion by the end of the period. The growth of this market can be attributed to the expansion of pharmaceutical manufacturing facilities, increased demand for biopharmaceuticals, rapid growth of contract manufacturing companies to drive market.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
US Periodontal Disease Treatment Market by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs) - Forecast to 2031
The US Periodontal Disease Treatment market, valued at USD 0.65 billion in 2025, stood at USD 0.68 billion in 2026 and is projected to advance at a resilient CAGR of 5.5% from 2026 to 2031, culminating in a forecasted valuation of USD 0.94 billion by the end of the period. Periodontal disease treatment in the US encompasses a wide range of technologies and solutions designed to support the diagnosis, treatment, and long-term management of gum-related conditions in dental practices.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune & Inflammatory, Neurology, Hematology, Infectious), Source (Human, Chimeric), Route (IV, SC) & Region - Global Forecast to 2028
The global antibody therapeutics market, valued at US$217.6 billion in 2022, stood at US$247.3 billion in 2023 and is projected to advance at a resilient CAGR of 14.1% from 2023 to 2028, culminating in a forecasted valuation of US$479.0 billion by the end of the period. Growth in the antibody therapeutics market is mainly driven by factors such as growing advancements in antibody engineering for development of novel therapeutics, growing R&D activities among others
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
C – Reactive Protein Testing Market by Assay Type (ELISA, Turbidimetric, Immunoturbidimetric), Application (Cardiovascular, Inflammatory Disease, Rheumatoid Arthritis, Cancer), End User (Hospitals, Clinics, Diagnostics Labs) - Global Forecast to 2023
The Global C-Reactive Protein Testing market is expected to reach USD 1.75 billion by 2023 from USD 1.62 billion in 2018, growing at a CAGR of 1.5 % from 2018 to 2023. Growing occurrences of Non Communicable Diseases (NCDs) such as Cardiovascular Diseases, Diabetes and other inflammatory diseases are the major drivers for this market. Point of Care technology for CRP testing is also being used for diagnostic purposes.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2024
The Lymphedema Diagnostics Market is expected to grow from USD 24 million in 2019 to USD 35 million by 2024, at a CAGR of 7.4% during the forecast period. The major players operating in the lymphedema diagnostics market are GE Healthcare (US), Philips (Netherlands), and Siemens Healthineers (Germany). Other prominent players in this market include Canon, Inc. (Japan), Shimadzu Corporation (Japan), Stryker Corporation (US), Fluoptics (France), United Imaging Healthcare Co., Ltd. (China), Hitachi, Ltd. (Japan), Esaote, SpA (Italy), Neusoft Corporation (China), Mindray Medical International, Ltd. (China), Mitaka USA, Inc. (US), Curadel, LLC (US), and ImpediMed Ltd. (Australia).
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
Autoimmunity Diagnostics Market by Product (Consumables, Instruments), Test Type (Routine, Autoantibody, Inflammatory, Urinalysis Tests), Disease (RA, SLE, MS, IBD), End User (Clinical Laboratories, Hospitals & Clinics) - Global Forecast to 2031
The global autoimmunity diagnostics market, valued at US$5.26 billion in 2024, stood at US$5.57 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2031, culminating in a forecasted valuation of US$8.98 billion by the end of the period. The autoimmunity diagnostics market is consistently growing, fueled by several key factors. These include the rising prevalence of autoimmune disease, growing awareness about early and accurate diagnosis, increasing research activities, and rapid advancements in diagnostic technologies.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Rotator Cuff Injury Treatment Market by Modality (Surgical (Arthroscopy, Shoulder Replacement, Tendon Repair), Physiotherapy (Braces, Cold Compression), Drug Therapeutics (Anti-inflammatory Drugs, Injections), Orthobiologics) - Global Forecast to 2026
The global rotator cuff injury treatment market growth is primed to transition from $989.3 million in 2021 to $1,244.2 million by 2026, showcasing a strong CAGR of 4.7%. The key factors fueling the growth of this market include an increase in sports-related shoulder injuries, technological advancements in arthroscopic surgical devices, increase in aging population with osteoarthritis, strong focus of players towards launch of highly advanced arthroscopic treatment devices.
- Published: April 2022
- Price: $ 4950
- TOC Available:
-
Stomach Cancer Treatment Market by Treatment, Type (Chemotherapy, Immunotherapy), Disease Indication (Gastric Cancer), Route of Administration, Drug Class (PD-1/PD-L1 inhibitors, HER2 antagonists), Distribution Channel - Global Forecast to 2027
The global stomach cancer treatment market is projected to reach USD 8 billion by 2027 from USD 4 Billion in 2022, at a CAGR of 14% during the forecast period
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
